Vlahovic, G., Archer, G., Lally-Goss, D., Reap, E., Batich, K., Desjardins, A., … Sampson, J. (2014). IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology, 16(suppl 5), v117–v117. https://doi.org/10.1093/neuonc/nou258.32

Vlahovic, G., G. Archer, D. Lally-Goss, E. Reap, K. Batich, A. Desjardins, K. Peters, et al. “IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v117–v117. https://doi.org/10.1093/neuonc/nou258.32.

Vlahovic G, Archer G, Lally-Goss D, Reap E, Batich K, Desjardins A, et al. IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology. 2014 Nov 1;16(suppl 5):v117–v117.

Vlahovic, G., et al. “IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v117–v117. Crossref, doi:10.1093/neuonc/nou258.32.

Vlahovic G, Archer G, Lally-Goss D, Reap E, Batich K, Desjardins A, Peters K, Ranjan T, Healy P, Herndon J, Friedman A, Friedman H, Bigner D, Sampson J. IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v117–v117.